Daily FNArena News - Small Caps

Expectations are on the rise for Life360 following second quarter results

Brokers raise target prices for Avita Medical following second quarter results amidst anticipation of exciting prospects in the outlook period

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market

Analysts raise target prices for SiteMinder after management brings forward the time frame for being free cash flow positive

Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports

Analysts remain positive on Syrah Resources despite current weak market conditions for graphite

Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics

Skin repair specialist PolyNovo remains confident in its firm growth path ahead

New research highlights Retail Food Group’s resilience to a consumer downturn and several capital-light growth opportunities

Brokers explain a negative share price reaction to Johns Lyng’s upgraded FY23 guidance